Skip to main content
Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
35.27
-1.08 (-2.97%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Harrow Revenue

In the year 2025, Harrow had annual revenue of $272.30M with 36.41% growth. Harrow had revenue of $89.09M in the quarter ending December 31, 2025, with 33.31% growth.

Revenue (ttm)
$272.30M
Revenue Growth
+36.41%
P/S Ratio
4.81
Revenue / Employee
$730,035
Employees
373
Market Cap
1.31B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025272.30M72.69M36.41%
Dec 31, 2024199.61M69.42M53.32%
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Phibro Animal Health 1.46B
Evotec SE 887.40M
ANI Pharmaceuticals 883.37M
Collegium Pharmaceutical 780.57M
Pacira BioSciences 726.41M
Amphastar Pharmaceuticals 719.89M
Revenue Rankings

HROW News

More News